Article
The Risk of Emerging Resistance to Trimethoprim/Sulfamethoxazole in Staphylococcus aureus
1 Aug 2022
Abstract excerpt
Objective: Due to the spread of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), the demand for trimethoprim/sulfamethoxazole (SXT) is increasing in the world. It is not clear whether the resistant strain emerges by overuse of SXT. We investigated here the emergent risk of the SXT-resistant mutant in S. aureus by an in vitro SXT exposure experiment. Methods: A total of 40 S. aureus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
